company background image
XPR logo

Exprivia BIT:XPR Voorraadrapport

Laatste prijs

€1.52

Marktkapitalisatie

€68.2m

7D

-16.0%

1Y

-3.8%

Bijgewerkt

18 Jul, 2024

Gegevens

Financiële gegevens bedrijf

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Exprivia S.p.A. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Exprivia
Historische aandelenkoersen
Huidige aandelenkoers€1.52
52 Week Hoogtepunt€2.08
52 Week Laag€1.49
Bèta1.08
11 maand verandering-11.63%
3 maanden verandering-10.59%
1 Jaar Verandering-3.80%
33 jaar verandering3.40%
5 jaar verandering50.50%
Verandering sinds IPO-93.77%

Recent nieuws en updates

Recent updates

Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Nov 18
Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

Sep 23
Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Aug 30
A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 10
Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Jun 14
What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Apr 04
Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Mar 01
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Feb 02
Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Nov 11
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Jul 08
Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Jun 10
Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Rendement voor aandeelhouders

XPRIT ITIT Markt
7D-16.0%0.2%0.06%
1Y-3.8%44.8%19.8%

Rendement versus industrie: XPR underperformed the Italian IT industry which returned 28.6% over the past year.

Rendement versus markt: XPR underperformed the Italian Market which returned 16.4% over the past year.

Prijsvolatiliteit

Is XPR's price volatile compared to industry and market?
XPR volatility
XPR Average Weekly Movement7.4%
IT Industry Average Movement4.1%
Market Average Movement4.1%
10% most volatile stocks in IT Market6.7%
10% least volatile stocks in IT Market2.5%

Stabiele aandelenkoers: XPR's share price has been volatile over the past 3 months.

Volatiliteit in de loop van de tijd: XPR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Italian stocks.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
n/a2,499Domenico Favuzziwww.exprivia.it

Exprivia S.p.A. Samenvatting

Hoe verhouden de winst en inkomsten van Exprivia zich tot de beurswaarde?
XPR fundamentele statistieken
Marktkapitalisatie€68.16m
Inkomsten(TTM)€13.14m
Inkomsten(TTM)€197.49m

5.2x

Koers/Winstverhouding

0.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
XPR resultatenrekening (TTM)
Inkomsten€197.49m
Kosten van inkomsten€173.65m
Brutowinst€23.84m
Overige uitgaven€10.70m
Inkomsten€13.14m

Laatst gerapporteerde inkomsten

Dec 31, 2023

Volgende inkomensdatum

Aug 06, 2024

Winst per aandeel (EPS)0.29
Brutomarge12.07%
Nettowinstmarge6.65%
Schuld/Eigen Vermogen Verhouding32.5%

Hoe presteerde XPR op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.2%

Huidig dividendrendement

n/a

Uitbetalingsratio